Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins;Verminderung der Ausdehnungsrate kleiner infrarenaler ortenaneurysmata durch statine

Vasa - Journal of Vascular Diseases

Volumn 41, Issue 1, 2012, Pages 35-42

  Periard, Daniel ^a   Guessous, Idris ^b,c   Mazzolai, Lucia ^b   Haesler, Erik ^b   Monney, Pierre ^b   Hayoz, Daniel ^a  

^a Hopital Cantonal de Fribourg   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Abdominal aortic aneurysm; Expansion; Medical therapy; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE PLUS SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG MEGADOSE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INFECTION; INFLAMMATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; TREATMENT DURATION; TREATMENT OUTCOME; ABDOMINAL AORTA; AORTOGRAPHY; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SWITZERLAND; TIME;

AGED; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; AORTOGRAPHY; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84858592850     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000161     Document Type: Article

References (20)

1. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002; 360: 1531-1539
2. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, Barone GW, Bandyk D, Moneta GL, Makhoul RG. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. The aneurysm detection and management study screening program: validation cohort and final results. Arch Intern Med. 2000; 160: 1425-1430.
3. The UK Small Aneurysm trial Participants (1998) Mortality results for randomised controlled trial of early elective surgery or ultrasono-graphic surveillance for small abdominal aortic aneurysm. Lancet 352: 1649-1655.
4. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, et al. (2006) ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease. Circulation 113: 463-654.
5. Guessous I, Periard D, Lorenzetti D, Cornuz J, Ghali WA. The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis. PLoS ONE. 2008; 3 (3): e1895.
6. Wilson WR, Evans J, Bell PR, Thompson MM. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2005; 30: 259-62.
7. Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol. 2006; 97: 279-280.
8. Schouten O, van Laanen JH, Bo-ersma E, Vidakovic R, Feringa HH, Dunkelgrun M, Bax JJ, Koning J, van Urk H, Poldermans D. Statins are associated with a reduced infra-renal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006; 32: 21-26.
9. Mosorin M, Niemelä E, Heikki-nen J, Lahtinen J, Tiozzo V, Satta J, Juvonen T, Biancari F. The use of statins and fate of small abdominal aortic aneurysms. Interact Cardio- vasc Thorac Surg. 2008; 7: 578-81.
10. Diehm N., Becker G., Katzen B., Benenati J., Kovacs M., Dick F., Statins are associated with de- creased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis. Vasa. 2008; 3: 241-249.
11. Cook TA, Galland RB. A prospec- tive study to define the optimum rescreening interval for small abdominal aortic aneurysm. Cardiovasc Surg 1996; 4: 441-4.
12. Santilli SM, Littooy FN, Cambria RA, et al. Expansion rates and out- comes for the 3.0-cm to the 3.9-cm infrarenal abdominal aortic aneurysm. J Vasc Surg 2002; 35: 666-71.
13. Ellis M, Powell JT, Greenhalgh RM. Limitations of ultrasonography in surveillance of small abdominal aortic aneurysms. Br J Surg. 1991; 78: 614-6.
14. Singh K, Jacobsen BK, Solberg S, Kumar S, Arnesen E. The difference between ultrasound and computed tomography (CT) measurements of aortic diameter increases with aortic diameter: analysis of axial images of abdominal aortic and common iliac artery diameter in normal and aneurysmal aortas. The Tromso Study, 1994-1995. Eur J Vasc En- dovasc Surg. 2004; 28: 158-67.
15. Monney P, Hayoz D, Tinguely F, Cornuz J, Haesler E, Mueller XM, von Segesser LK, Tevaearai HT. High prevalence of unsuspected abdominal aortic aneurysms in patients hospitalised for surgical coronary revascularisation. Eur J Cardiothorac Surg. 2004; 25: 65-8.
16. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, et al. Use of dox-ycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg. 2001; 34: 606-10.
17. Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expan- sion. Br J Surg. 2001; 88: 1066-72.
18. Diehm N, Dick F, Katzen BT, Do DD, Baumgartner I. Endovascular repair of abdominal aortic aneurysms: only a mechanical solution for a biological problem? J Endovasc Ther. 2009; 16 Suppl 1: 19-26.
19. Hackam DG, Thiruchelvam D, Re-delmeier DA. Angiotensin-conver- ting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet. 2006; 19; 368: 659-65.
20. Sweeting MJ, Thompson SG, Brown LC, Greenhalgh RM, Powell JT. Use of angiotensin converting enzyme inhibitors is associated with in-creased growth rate of abdominal aortic aneurysms. J Vasc Surg. 2010; 52: 1-4.